"Rail travel at high speeds is not possible because passengers, unable to breathe, would die of asphyxia."
Dionysius Lardner, Professor of Natural Philosophy and Astronomy at University College, London ; 1830
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7371885 | Cis-trans isomerisation of semicarbazone compounds The present invention relates to the isomerization of the Z-isomer I-Z of semicarbazone compounds of the general formula (I) into its E-isomer I-E, where the variables in formula (I) have meanings given in claim 1 ... | 05/13/2008 |
| 7288572 | Active substance combinations having insecticidal and acaricidal properties The present invention relates to novel insecticidally and acaricidally active compound combinations of N2-[1,1-dimethyl-2-(methylsulphonyl)ethyl]-3-iodo-N1-{2-methyl-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl}phthalamide of the form... | 10/30/2007 |
| 7279597 | Phenyl amine carboxylic acid compounds and compositions for delivering active agents Phenyl amine carboxylic acid compounds and compositions for the delivery of active agents are provided. Methods of administration and preparation are provided as well. ... | 10/09/2007 |
| 7129274 | Phenoxy carboxylic acid compounds and compositions for delivering active agents Phenoxy carboxylic acid compounds and compositions for the delivery of active agents are provided. Methods of administration and preparation are provided as well. ... | 10/31/2006 |
| 7091210 | Substituted 2-aminoacetamides and the use thereof The invention is directed to substituted 2-aminoacetamides represented by formula (II): and to pharmaceutically acceptable salts thereof, wherein the substituents are defined herein, for use in the treatment or a... | 08/15/2006 |
| 6956132 | Process for producing 2-phenylacetophenone derivatives and precursors therefor A process for producing 2-phenylacetophenone derivatives represented by the formula (I): (wherein X is an alkyl group or a haloalkyl group, and Y is a hydrogen atom, a halogen atom or an alkyl group which may be substi... | 10/18/2005 |
| 6943179 | Biurethane derivatives Novel compounds of the formula I in which X, Y, Z, R, R1, R2 and R3 are as defined in Patent Claim 1, are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of tromboembolic diseases and... | 09/13/2005 |
| 6903237 | Ectoparasitic insect pest controllers for animals and their usage Ectoparasitic insect pest controllers for animals, containing hydrazine derivatives of the general formula (I) as the active ingredient, and methods for application of the same: (I) [wherein A is (II), (III), (IV), (V) (wherein R4 and R5 are ea... | 06/07/2005 |
| 6897240 | Thio semicarbazone and semicarbazone inhibitors of cysteine proteases and methods of their use The present invention relates to thio semicarbazone and semicarbazone inhibitors of cysteine proteases and methods of using such compounds to prevent and treat protozoan infections such as trypanosomiasis, malaria and leishmaniasis. The compounds also find use in in... | 05/24/2005 |
| 6849626 | Aza-amino acid derivatives (factor Xa inhibitors 15) The invention relates to semicarbazides of the general formula I where R1, R2, R3, R4 and I have the meaning indicated in claim 1. The compounds of the formul... | 02/01/2005 |
| 6841701 | Inhibitors for the blood-clotting factor Xa The invention relates to derivatives of amidino-benzylamine, especially derivatives of 4-amidino-benzylamine, with two bonded amino acids. These derivatives represent a novel group of highly active and very selective F Xa-inhibitors for treating cardiovascular disea... | 01/11/2005 |
| 6696442 | Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof This invention is related to carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones represented by Formula I: ##STR1## or a pharmaceutically acceptable salt or prodrug thereof, wherein: Y is oxygen or sulfur; R1, R21... | 02/24/2004 |
| 6638947 | Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof This invention is related to carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones represented by Formula I: ##STR1## or a pharmaceutically acceptable salt or prodrug thereof, wherein: Y is oxygen or sulfur; R1, R21... | 10/28/2003 |
| 6613803 | Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof This invention is related to carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones represented by Formula I: ##STR1## or a pharmaceutically acceptable salt or prodrug thereof, wherein: Y is oxygen or sulfur; R1, R21... | 09/02/2003 |
| 6610715 | Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same The present invention provides novel cathecol hydrazone derivatives of formula (I) or pharmaceutically acceptable salts thereof, wherein R1 is C1-7 alkyl or C3-7 cycloalkyl; R2 is hydrogen, hydroxy, C1-5 | 08/26/2003 |
| 6593362 | Non-peptidic cyclophilin binding compounds and their use This invention relates to pharmaceutical compositions and methods of using non-peptidic cyclophilin-binding compounds in medical conditions involving breakdown of mitochondrial energy metabolism induced by calcium overload, in treating alopecia and promot... | 07/15/2003 |
| 6566304 | Biogenic control and limitation of the reproduction of parasitic earth nematodes in stock culture The invention relates to use of (a) compounds of phosphorus containing at least partly lipophilic organic radicals together with (b) urea and/or urea derivatives in selected quantity ratios of (a) to (b) as a soil additive for biologically controlling pla... | 05/20/2003 |
| 6479543 | Synergistic insecticidal compositions The present invention provides a synergistic insecticidal composition comprising as essential active ingredients a neuronal sodium channel antagonist in combination with one or more compounds selected from the group consisting of pyrethroids, pyrethroid-t... | 11/12/2002 |
| 6331542 | Protease inhibitors The present invention provides compounds which inhibit proteases, including cathepsin K, pharmaceutical compositions of such compounds, and methods for treating diseases of excessive bone loss or cartilage or matrix degradation, including osteoporosis; gi... | 12/18/2001 |
| 6291464 | Aminopiperazine derivatives This invention relates to new aminopiperazine derivatives having the potentiation of the cholinergic activity, etc., and represented by general formula [I]. ##STR1## wherein R1 is lower alkyl, etc., R2 is aryl, etc., A is ##STR2## or --SO | 09/18/2001 |
| 6284777 | Carbohydrazide protease inhibitors The present invention provides compounds which inhibit proteases, including cathepsin K, pharmaceutical compositions of such compounds, and methods for treating diseases of excessive bone loss or cartilage or matrix degradation, inducing osteoporosis; gin... | 09/04/2001 |
| 6281211 | Substituted semicarbazides and the use thereof This invention is related to substituted semicarbazides represented by Formula (I) or a pharmaceutically acceptable salt or prodrug thereof, wherein: R1 and R2 are independently hydrogen, alkyl, cycloalkyl, alkenyl, alkynyl, haloalky... | 08/28/2001 |
| 6077866 | Benzophenone hydrazone derivatives as insecticides Novel benzophenonehydrazone derivatives represented by the formula (I): ##STR1## wherein, R1 is halogen; R2 is hydrogen or C1-4 alkyl; R3 is cyano, optically substituted C1-4 alkyl, C2-4 ... | 06/20/2000 |
| 6034137 | Cationic lipids for gene therapy This invention provides novel cationic lipids, particularly guanidino lipids, and methods for their preparation. Also provided are polyanionic-lipid complexes comprising the lipids of the invention, their preparation and use to deliver biologically active... | 03/07/2000 |
| 6011047 | Substituted 3-amino-2-hydroxyphenylacetamide derivatives as enzyme inhibitors The present invention provides peptide aldehydes having a 3-amino-2-hydroxyphyenyl-acetamide group as part of the peptide backbone and an arginine mimic group such as an amidinopiperidine or amidinophenyl tail. These compounds are potent and specific inhi... | 01/04/2000 |
| 5919816 | Formulations and methods of reducing toxicity of antineoplastic agents This invention provides for pharmaceutical formulations of compounds which are useful as protective agents when administered to patients also receiving antineoplastic drugs. The invention also includes methods of reducing the toxicity of various antineopl... | 07/06/1999 |
| 5811456 | Monoamine oxidase B inhibitors, processes for their preparation and use thereof Novel monoamine oxidase B inhibitors of formula (I), wherein R1 .dbd.H, an optionally substituted benzyloxy or phenylethoxy group; p=0-3; R3 .dbd.H, a CN, OH, CCH group, a C1 -C3 alkoxy-carbonyl group, or a C | 09/22/1998 |
| 5776925 | Methods for cancer chemosensitization Methods for cancer chemosensitization are provided. Texaphyrins are new chemosensitizers for enhancing the cytotoxicity of chemotherapeutic agents. The enhancement appears to be P-glycoprotein-independent since texaphyrins are effective in both a P-glycop... | 07/07/1998 |
| 5741818 | Semicarbazones having CNS activity and pharmaceutical preparations containing same A compound of general formula I below useful as an anticonvulsant for disorders of the central nervous system: ##STR1## wherein: R1, R2, R3 and R4 may be the same or different and each represents a hydrogen... | 04/21/1998 |
| 5637619 | Antitumor 2-aminocarbonyl-1, 2-bis(methylsulfonyl)-1-(substituted)hydrazines The present invention relates to novel 2-aminocarbonyl-1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazines and 2-aminocarbonyl-1,2-bis(methylsulfonyl)-1-methylhydrazines, and their use to treat malignant tumors. The agents are especially useful in the ... | 06/10/1997 |
| 5589510 | Method for inhibiting retroviral infection by administering a naphthalenesulfonic acid compound A method for inhibiting retroviral infection in a subject comprising administering to said subject a therapeutically effective amount of a naphthalenesulfonic acid compound or a pharmaceutically acceptable salt thereof, as herein defined.... | 12/31/1996 |
| 5571843 | Derivatives of indan-1,3-dione and indan-1,2,3-trione, methods of preparing them and therapeutic use thereof Therapeutic compounds having the formula: ##STR1## in which R2 and R3 independently denote H, C1 -C4 alkoxy or OH and (A, B)=(oxygen, oxygen) in which case one out of R and R1 denotes OH, halogen... | 11/05/1996 |
| 5543573 | Hydrazinecarboxyamide derivatives, a process for production thereof and uses thereof The present invention relates to a hydrazinecarboxamide derivative of the general formula (I) shown below: ##STR1## wherein the substituents are as defined in the specification, which has a wide insecticidal spectrum at a low dosage, a process for pr... | 08/06/1996 |
| 5523322 | Method for inhibiting blood-platelet aggregration with ଲ-naphthoquinone compounds A method of inhibiting blood-platelet aggregation in warm-blooded animals comprising administering to warm-blooded animals a blood-platelet aggregation inhibiting effective amount of a compound selected from the group consisting of a compound of the formu... | 06/04/1996 |
| 5478821 | Method of accelerating the proliferation of emdothelial cells with inhibition of no synthases A method of accelerating the proliferation of endothelial cells with inhibition of NO synthases in warm-blooded animals comprising administering to warm-blooded animals an amount of at least one compound selected from the group consisting of a ଲ-nap... | 12/26/1995 |
| 5461076 | Hydrazones Compounds of formula I ##STR1## wherein A, X, Z and R1 -R5 are as defined in the description, and their salts have valuable pharmaceutical properties and are effective especially against tumors. They are prepared in a manner kno... | 10/24/1995 |
| 5395855 | Hydrazones Compounds of formula I ##STR1## wherein A, X, Z and R1 -R5 are as defined in the description, and their salts have valuable pharmaceutical properties and are effective especially against tumors. They are prepared in a manner kno... | 03/07/1995 |
| 5376685 | Arylhydrazones using as SAMDC inhibitors Compounds of formula I ##STR1## wherein A, X1, X2, X3, X4, Y, Z and R1 to R6 have the meanings given in the description, have valuable pharmaceutical properties and are effective espec... | 12/27/1994 |
| 5185375 | Thioformamide derivatives Therapeutically useful thioformamide derivatives of the formula: ##STR1## wherein R represents alkyl, Ar represents optionally substituted phenyl group, Y represents ethylene, methylene or a valency bond, and X represents carbonyl, hydroxymethylene, ... | 02/09/1993 |
| 5137877 | Bifunctional linking compounds, conjugates and methods for their production The present invention provides novel N-substituted hydrazine bifunctional compounds, novel N-subhstituted hydrazone derivatives of a cytotoxic reagent incorporating the bifunctional compounds, novel conjugates containing at least one cytotoxic reagent mol... | 08/11/1992 |